ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: knee

In Memoriam: John Bland, MD

Paul Plotz, MD  |  

John Hardesty Bland, MD, professor of medicine emeritus at the University of Vermont College of Medicine in Burlington, died on March 15, 2007. He was midway through his 90th year, fulfilling the prescription of his last book, Live Long, Die Fast: Playing the Aging Game to Win, published when he was 80. A consummate rheumatologist and wonderful bedside doctor and teacher, Dr. Bland was also one of the genuine polymaths in the American medical world.

Osteonecrosis

  |  

Osteonecrosis, also called avascular necrosis or aseptic necrosis, is a condition in which the death of bone cells (due to decreased blood flow) can lead to pain and collapse of areas of bone. This collapse of bone, in turn, can lead to degenerative arthritis of nearby joints, most commonly the hips and knees. Less frequently affected are the shoulders, hands, and feet. In rare instances, osteonecrosis can occur in the jaw— resulting in pain and mouth ulceration. Osteonecrosis is not fatal, but can lead to pain, arthritis, problems with physical activity, and even the need for joint replacement. Most of the 10,000 to 20,000 Americans developing osteonecrosis annually are between age 20 and 50. These individuals usually have a history of serious trauma, corticosteroid use, excess alcohol intake, or other conditions including systemic lupus erythematosus, dysbarism (“the bends” that occur with scuba diving), blood disorders, HIV infection, and radiation therapy.

Marc C. Hochberg, MD, MPH, Named PI for Upcoming OA Guidelines

  |  

The ACR has named Marc C. Hochberg, MD, MPH, as the principal investigator (PI) for the upcoming, “Guidelines for the Management of Osteoarthritis [OA] of the Hip, Knee, and Hand.” Dr. Hochberg is professor of medicine and epidemiology and preventive medicine and head of the division of rheumatology and clinical immunology at the University of Maryland School of Medicine in Baltimore.

How Medically Unlikely Edits Affect a Practice

  |  

Medically unlikely edits (MUEs), formally known as medically unbelievable edits, took effect with the Centers for Medicare & Medicaid Services (CMS) on January 2, 2007. The function of MUEs is to detect and deny unlikely CMS claims on a pre-payment basis with the intention of improving Medicare’s payment process.